71 completed, 9 unknown, 7 terminated, 6 recruiting. 96 Phase 3, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 96 | Completed 71, Unknown 9, Terminated 7, Recruiting 6, Withdrawn 3 |
| Phase 2 | 6 | Unknown 3, Completed 2, Terminated 1 |
Follow Lens Diseases: new trials by email Literature Review of Lens Diseases trials Research Report on Lens Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone) Bimatoprost Implant System, SpyGlass IOL, Timolol Maleate Ophthalmic Solution, 0.5% - Cataract, Glaucoma | Phase 3 | Recruiting | SpyGlass Pharma, Inc. | 400 | 2025-10-28 | 2025-10-20 |
| Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine) Bimatoprost Implant System, SpyGlass IOL, Timolol Maleate Ophthalmic Solution, 0.5% - Cataract, Glaucoma | Phase 3 | Recruiting | SpyGlass Pharma, Inc. | 400 | 2025-10-15 | 2025-10-20 |
| Intranasal Dexmedetomidine on Blood Pressure in Elderly Hypertensive Patients Undergoing Cataract Surgery Intranasal dexmedetomidine, Intranasal normal saline - Cataract, Hypertension | Phase 3 | Recruiting | Suez Canal University | 126 | 2025-07-16 | 2026-04-07 |
| Treatment of Retinal Detachment in People Who Have Not Had Cataract Surgery With Vitrectomy vs Vitrectomy and Cataract Removal Phacovitrectomy, Vitrectomy - Rhegmatogenous Retinal Detachment | Phase 3 | Recruiting | Queen's University, Belfast | 276 | 2025-05-16 | 2026-10-27 |
| The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery Ripasudil, Placebo - Fuchs' Endothelial Dystrophy, Cataract | Phase 3 | Recruiting | Singapore Eye Research Institute | 120 | 2025-03-01 | 2025-01-29 |
| A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR) MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet - Cataract | Phase 3 | Unknown | Melt Pharmaceuticals | 528 | 2024-05-01 | 2024-08-02 |
| A Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Cataract Surgery (2) Dexycu, Placebo/Vehicle - Cataract | Phase 3 | Withdrawn | EyePoint Pharmaceuticals, Inc. | 2022-09-01 | 2024-04-03 | |
| A Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Cataract Surgery Dexycu, Placebo/Vehicle - Cataract | Phase 3 | Withdrawn | EyePoint Pharmaceuticals, Inc. | 2022-09-01 | 2025-08-11 | |
| Study of Dexycu in Treating Intraocular Inflammation Dexycu, Placebo - Inflammation, Cataract | Phase 3 | Completed | Ocumension Therapeutics (Shanghai) Co., Ltd | 285 | 2022-08-22 | 2024-08-26 |
| Effectiveness of Periocular Drug Injection in CATaract Surgery Bromfenac, Dexamethasone, Triamcinolone Acetonide - Macular Edema, Cystoid Macular Edema | Phase 3 | Terminated | Luigi Rondas | 628 | 2021-10-13 | 2024-11-04 |
| Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery The study will include three arms, one non interventional and 2 interventions. The intervention arms will include two commercially available sodium hyaluronate 0.1% (Systane ultra plus and Hylo-comod) - Dry Eye Disease, Dry Eye Syndrome | Phase 3 | Unknown | Fundación Oftalmológica Los Andes | 100 | 2021-01-15 | 2021-01-15 |
| Hypochlorous Acid Disinfection Prior to Cataract Surgery Hypochlorous Acid Gel 0.02% - Cataract, Endophthalmitis | Phase 3 | Completed | Loma Linda University | 54 | 2020-10-29 | 2023-02-21 |
| Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes. Triamcinolone Acetonide - Diabete Type 2, Cataract | Phase 2 / Phase 3 | Completed | Damascus University | 73 | 2020-09-12 | 2023-04-26 |
| Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Chloroprocaine 3%, Tetracaine 0.5% - Cataract | Phase 3 | Completed | Sintetica SA | 338 | 2020-09-09 | 2023-01-18 |
| A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Dextenza Ophthalmic Insert, Prednisolone acetate ophthalmic suspension USP 1% - Cataract | Phase 3 | Completed | Ocular Therapeutix, Inc. | 65 | 2020-09-04 | 2024-04-15 |
| Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1) Clobetasol propionate, Vehicle - Cataract | Phase 3 | Completed | Salvat | 250 | 2020-06-10 | 2022-12-22 |
| Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2) Clobetasol Propionate, Vehicle - Cataract | Phase 3 | Completed | Salvat | 215 | 2020-06-04 | 2022-12-22 |
| Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery Lucentis - Diabetic Macular Edema, Cataract | Phase 3 | Unknown | Second Military Medical University | 90 | 2019-08-22 | 2020-03-26 |
| Evaluation of Treatment Option for Demodicosis in Patients Undergoing Cataract Surgery Tea Tree Oil Shampoo, Ciprofloxacin Ophthalmic Ointment 0.3%, Baby shampoo - Demodex Infestation, Demodicosis | Phase 2 / Phase 3 | Completed | Hospital de La Luz | 160 | 2019-05-06 | 2020-04-27 |
| Pilocarpine Use After Kahook Goniotomy Pilocarpine, Prednisolone, Ofloxacin - Glaucoma | Phase 3 | Recruiting | Montefiore Medical Center | 142 | 2019-05-01 | 2025-11-10 |
Showing 20 of 96. Sign in to see all of them.
Cataract (95) · Inflammation (17) · Pain (12) · Glaucoma (7) · Macular Degeneration (4) · Macular Edema (4) · Diabetes Mellitus, Type 2 (3) · Glaucoma, Open-Angle (3) · Corneal Endothelial Cell Loss (2) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 1 (2) · Dry Eye Syndromes (2) · Neoplasms (2) · Ocular Hypertension (2) · Aphakia (1)
Eye Diseases (95) · Pathological Conditions, Signs and Symptoms (21) · Pathologic Processes (20) · Signs and Symptoms (14) · Neurologic Manifestations (12) · Retinal Degeneration (8) · Retinal Diseases (8) · Ocular Hypertension (6) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Endocrine System Diseases (4) · Glucose Metabolism Disorders (4) · Macular Degeneration (4) · Cardiovascular Diseases (3)
Calcium Dobesilate (6) · Cataract Extraction (5) · nepafenac (5) · prednisolone acetate (5) · Dexamethasone (4) · Loteprednol Etabonate (4) · R-1,1,1-trifluoro-4-(5-fluoro-2,3-dihydrobenzofuran-7-yl)-4-methyl-2-(((2-methyl-5-quinolyl)amino)methyl)pentan-2-ol (4) · bromfenac (4) · Methylprednisolone (3) · Phacoemulsification (3) · Triamcinolone Acetonide (3) · Aspirin (2) · BID protein, human (2) · Clobetasol (2) · D-JNKI-1 (2)
Alcon Research (14) · Bausch & Lomb Incorporated (14) · Abbott Medical Optics (5) · National Eye Institute (NEI) (5) · Glaukos Corporation (3) · Omeros Corporation (3) · EyePoint Pharmaceuticals, Inc. (2) · ICON Bioscience Inc (2) · Kala Pharmaceuticals, Inc. (2) · LensAR Incorporated (2) · Salvat (2) · SpyGlass Pharma, Inc. (2) · Xigen SA (2) · Actavis Inc. (1) · Amgen (1)
United States (51) · Mexico (5) · France (4) · Germany (4) · India (4) · Italy (4) · China (3) · Netherlands (3) · Austria (2) · Brazil (2) · Canada (2) · Egypt (2) · Hungary (2) · Portugal (2) · Singapore (2)
Steve Whitaker, MD (3) · Andrew Schwartz, MD (2) · Jeff Wells, PharmD, MBA (2) · Paul Yoo, OD (2) · Rabia Ozden, MD (2) · Stephen Lane (2) · Tim McNamara, PharmD (2) · Abhay R Vasavada, MS, FRCS (1) · Aldo Caporossi, MD, Prof. (1) · Andrew Maxwell (1) · Aung Tin, PhD MD (1) · Blake Harris (1) · Bradley Williams, MD (1)
PMID 12424394, PMID 14977340, PMID 24935281, PMID 27810317, PMID 28670710, PMID 42192627, PMID 10801969, PMID 11097601, PMID 11470690, PMID 11594942, PMID 11594943, PMID 11925463, PMID 15136320, PMID 15534261, PMID 15808240, PMID 16019690, PMID 16606880, PMID 16877067, PMID 17502507, PMID 17559787, PMID 17846363, PMID 18201681, PMID 18387406, PMID 18421079, PMID 18779490, PMID 19237716, PMID 19508997, PMID 19636163, PMID 19668532, PMID 20828829, PMID 21397456, PMID 21751945, PMID 22317913, PMID 22814041, PMID 22879423, PMID 23620429, PMID 23644932, PMID 23645227, PMID 23830564, PMID 23887802, PMID 24310343, PMID 24638908, PMID 24974812, PMID 25085962, PMID 25232809, PMID 26305649, PMID 26531052, PMID 27519183, PMID 27526051, PMID 29661413
2005 (1), 2009 (1), 2016 (1), 2019 (1), R01EY014418 (1), U10CA037429 (1)